Our Firm is representing hundreds of DePuy Pinnacle lawsuit clients in this proceeding, and we are pleased to see it moving forward. We look forward to the commencement of trials later this year.
New York, New York (PRWEB) May 08, 2014
The federal court overseeing thousands of DePuy Pinnacle hip lawsuit (http://www.depuypinnacle-lawsuit.com/ ) claims alleging injury due to a metal-on-metal version of the Pinnacle Hip Replacement System held its most recent Status Conference on April 10, 2014. According to a transcript of that conference issued in the U.S. District Court, Northern District of Texas, on May 5th, there are now roughly 6,000 DePuy Pinnacle lawsuits pending in the proceeding. It was also reported that discovery, including the deposition of witnesses, is on track for the litigation’s first bellwether trials, which are scheduled to begin this fall. (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation, MDL No. 2244)
“Our Firm is representing hundreds of DePuy Pinnacle lawsuit clients in this proceeding, and we are pleased to see it moving forward. We look forward to the commencement of trials later this year,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of dangerous drugs and medical devices. The Firm continues to offer free case reviews to individuals who may have been injured by the all-metal DePuy Pinnacle hip implant.
Pinnacle Hip Lawsuits
According to court documents, all of the Pinnacle hip lawsuits pending in the Northern District of Texas involve an all-metal version of the hip system that utilizes the Ultamet liner. Jeffrey S. Grand, a partner with Bernstein Liebhard LLP, is serving on the Plaintiffs’ Steering Committee in the federal Pinnacle litigation.
Court records indicate that all of the claims filed in the Northern District of Texas involve recipients of a metal-on-metal version of the Pinnacle hip that utilizes the Ultamet Liner. Plaintiffs allege that this design causes the hip to shed dangerous amounts of toxic metal debris into recipients’ blood stream and surrounding tissue, resulting in metallosis, pseudotumor formation, and other serious complications that have the potential to cause premature failure of the implant. Finally, plaintiffs assert that this alleged design flaw is similar to the issue that resulted in the 2010 recall of DePuy’s ASR hip implants, and question whether or not the metal-on-metal Pinnacle should have been recalled as well.
In January 2013, the U.S. Food & Drug Administration (FDA) warned that metal-on-metal hip implants may be more vulnerable to premature failure compared to devices made from other materials. The agency recommended metal ion blood testing for all-metal hip patients who are experiencing pain, swelling, or other symptoms that could be a symptom of hip failure. The FDA has also recommended stricter regulations for metal-on-metal hip implants, including a requirement that devices currently on the market undergo safety studies if their manufacturers intend to keep selling them.
According to a Bloomberg.com report from May 2013, the FDA’s stance on metal-on-metal hips helped to prompt a decision by DePuy Orthopaedics to end sales of such devices, including the all-metal Pinnacle.*
Recipients of the all-metal Pinnacle hip replacement may be entitled to compensation if they allegedly suffered metallosis, chronic pain, pseudotumor formation, premature device failure or other problems related to its metal-on-metal design. To learn more about filing a DePuy Pinnacle lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free, no obligation review of your case, please call 800-511-5092 today.
*bloomberg.com/news/2013-05-16/j-j-will-stop-sales-of-metal-on-metal-hip-replacements.html, Bloomberg.com, May 17, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP